WHO Classifies Hepatitis D as Carcinogenic

The World Health Organization (WHO) has reclassified the Hepatitis D Virus (HDV) as a carcinogen, underscoring its potential to cause cancer, particularly in individuals already infected with the Hepatitis B Virus (HBV). This development is crucial for UPSC aspirants, especially for General Studies Paper 2, as it highlights the importance of public health policies. Last Updated: 2025-08-08

Key Facts About WHO's Classification of Hepatitis D

• WHO reclassifies Hepatitis D as carcinogenic, indicating a significant cancer risk.
• Hepatitis D occurs only in individuals infected with the Hepatitis B Virus (HBV).
• Advocacy for Hepatitis B vaccination is crucial to mitigate risks.
• Hepatitis D can cause liver inflammation, leading to severe conditions.
• Symptoms include fever, fatigue, dark urine, and jaundice.
• Caused by hepatotropic viruses and factors like alcohol and autoimmune hepatitis.
• In 2022, approximately 254 million cases of Hepatitis B were reported.
• Diagnosis of Hepatitis D relies on the HDV-RNA test.
• Emerging treatments such as bulevirtide show promise.
• WHO strategy aims to reduce new infections by 90% by 2030.

Global Health Implications of Hepatitis D

The reclassification of Hepatitis D as a carcinogen by the WHO has significant implications for global health, aligning with India's strategic goals of improving public health outcomes. The emphasis on Hepatitis B vaccination is crucial for reducing co-infection rates and preventing liver cancer. India's commitment to universal healthcare and disease prevention aligns with WHO's strategy to reduce new infections by 90% by 2030. This reclassification is expected to enhance global surveillance and funding, contributing to better health outcomes worldwide.

Related Government Schemes/Policies

• National Viral Hepatitis Control Program (NVHCP): Aims to combat hepatitis through prevention, diagnosis, and treatment.
• Universal Immunization Program (UIP): Provides free Hepatitis B vaccination to infants.

UPSC Relevance

• GS Paper 2: Health policies and interventions, international health organizations.
• Prelims: Questions on WHO classifications, Hepatitis B and D, vaccination programs.
• Mains: Analytical themes on public health strategies, disease prevention, and international cooperation.
• Essay Paper: Topics on global health challenges and India's role in international health initiatives.

FAQ Section

• What is Hepatitis D?
  Hepatitis D is a liver infection caused by the Hepatitis D Virus (HDV), which only occurs in individuals already infected with the Hepatitis B Virus (HBV).
• Why is Hepatitis D important?
  Hepatitis D is important due to its potential to cause severe liver conditions, including cancer, especially when co-infected with HBV. WHO's reclassification as a carcinogen highlights its public health significance.
• What are the key features of Hepatitis D?
  Key features include liver inflammation, symptoms like jaundice and fatigue, and increased risk of liver cirrhosis and cancer. Diagnosis is confirmed through the HDV-RNA test, and emerging treatments like bulevirtide offer hope.